As of 2025-07-23, the EV/EBITDA ratio of CanSino Biologics Inc (688185.SS) is -40.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 688185.SS's latest enterprise value is 10,438.75 mil CNY. 688185.SS's TTM EBITDA according to its financial statements is -260.49 mil CNY. Dividing these 2 quantities gives us the above 688185.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 22.9x | 18.6x |
| Forward P/E multiples | 11.0x - 12.2x | 11.6x |
| Fair Price | (27.40) - 70.20 | 15.64 |
| Upside | -141.4% - 6.1% | -76.3% |
| Date | EV/EBITDA |
| 2025-06-19 | -35.27 |
| 2025-06-18 | -35.88 |
| 2025-06-17 | -36.55 |
| 2025-06-16 | -36.96 |
| 2025-06-13 | -36.78 |
| 2025-06-12 | -37.72 |
| 2025-06-11 | -37.22 |
| 2025-06-10 | -37.37 |
| 2025-06-09 | -37.52 |
| 2025-06-06 | -36.24 |
| 2025-06-05 | -36.27 |
| 2025-06-04 | -36.59 |
| 2025-06-03 | -36.75 |
| 2025-05-30 | -35.76 |
| 2025-05-29 | -35.69 |
| 2025-05-28 | -34.39 |
| 2025-05-27 | -35.17 |
| 2025-05-26 | -34.85 |
| 2025-05-23 | -35.07 |
| 2025-05-22 | -35.46 |
| 2025-05-21 | -36.20 |
| 2025-05-20 | -35.12 |
| 2025-05-19 | -34.34 |
| 2025-05-16 | -35.14 |
| 2025-05-15 | -33.97 |
| 2025-05-14 | -34.16 |
| 2025-05-13 | -34.13 |
| 2025-05-12 | -34.11 |
| 2025-05-09 | -34.13 |
| 2025-05-08 | -34.83 |
| 2025-05-07 | -34.74 |
| 2025-05-06 | -34.86 |
| 2025-04-30 | -34.69 |
| 2025-04-29 | -33.32 |
| 2025-04-28 | -33.04 |
| 2025-04-25 | -33.37 |
| 2025-04-24 | -33.52 |
| 2025-04-23 | -33.76 |
| 2025-04-22 | -33.85 |
| 2025-04-21 | -33.69 |
| 2025-04-18 | -33.02 |
| 2025-04-17 | -33.14 |
| 2025-04-16 | -33.03 |
| 2025-04-15 | -33.77 |
| 2025-04-14 | -34.57 |
| 2025-04-11 | -33.78 |
| 2025-04-10 | -33.49 |
| 2025-04-09 | -32.33 |
| 2025-04-08 | -32.06 |
| 2025-04-07 | -30.44 |